BioMarin Pharmaceutical Inc (BMRN) News

BioMarin Pharmaceutical Inc (BMRN): $61.53

0.28 (+0.46%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

C

Add BMRN to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#13 of 337

in industry

Filter BMRN News Items

BMRN News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

BMRN News Highlights

  • 404 Page not found

    Error: Page not found

    The requested URL was not found on this server.

  • 404 Page not found

    Error: Page not found

    The requested URL was not found on this server.

  • 404 Page not found

    Error: Page not found

    The requested URL was not found on this server.

Latest BMRN News From Around the Web

Below are the latest news stories about BIOMARIN PHARMACEUTICAL INC that investors may wish to consider to help them evaluate BMRN as an investment opportunity.

Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Yahoo | January 10, 2025

Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Growth Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Yahoo | January 9, 2025

Zacks.com featured highlights include Leidos, Amazon.com, Halozyme Therapeutics and BioMarin Pharmaceutical

Leidos, Amazon.com, Halozyme Therapeutics and BioMarin Pharmaceutical are part of the Zacks Screen of the Week article.

Yahoo | January 7, 2025

These 4 Stocks Boast Impressive Interest Coverage Ratios

LDOS, AMZN, HALO & BMRN's impressive interest coverage ratios highlight that these companies can withstand financial hardships.

Yahoo | January 6, 2025

BioMarin to Present at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, at 9:00 am PT / 12:00 pm ET, in San Francisco, CA

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Alexander Hardy, President and Chief Executive Officer of BioMarin, will present at the 43rd Annual J.P. Morgan Conference on Monday, January 13, 2024, at 9:00 am PT / 12:00 pm ET, in San Francisco, California.

Yahoo | January 6, 2025

10 Magnificent Stocks That Can Make You Richer in 2025

A new year brings with it new opportunities to grow your wealth on Wall Street.

Yahoo | January 3, 2025

3 Reasons Why Growth Investors Shouldn't Overlook BioMarin (BMRN)

BioMarin (BMRN) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Yahoo | January 2, 2025

BMRN or TECH: Which Is the Better Value Stock Right Now?

BMRN vs. TECH: Which Stock Is the Better Value Option?

Yahoo | January 2, 2025

Why BioMarin Pharmaceutical (BMRN) is a Top Value Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Yahoo | December 26, 2024

Why BioMarin Pharmaceutical (BMRN) is a Top Growth Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Yahoo | December 24, 2024


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!